Similar Search Results

Patents, Partnerships, and the Pre-Competitive Collaboration Myth in Pharmaceutical Innovation

Vertinsky, Liza - 2015

Public-private partnerships offer a promising alternative paradigm for pharmaceutical innovation in complex disease … essential to accelerate pharmaceutical innovation. Patents threaten the potential of partnership strategies, however, by making … innovation is fundamentally flawed for two reasons. First, it ignores the competitive market pressures that both shape what is …

Persistent link: https://www.econbiz.de/10014136820

The rise of spin-offs : fueling pharmaceutical innovation through collaboration

Yashiro, Kentaro; Lim, Yeongjoo; Sengoku, Shintaro; … - In: Journal of open innovation : technology, market, and … 10 (2024) 1, pp. 1-11

Collaboration among various organizations is important for the sustainable creation of new innovative drugs. Previously, drug discovery was dominated by large pharmaceutical companies; however, various new players are now actively involved in this endeavor. Nevertheless, the factors affecting...

Persistent link: https://www.econbiz.de/10014518795

The impact of R&D cooperations on drug variety offered on the market : evidence from the pharmaceutical industry

Banerjee, Tannista; Siebert, Ralph - 2014

Our study puts special attention to the fact that R&D cooperations in the pharmaceutical industry are formed at different stages throughout the drug development process. We study if the timing to engage in R&D cooperations in the pharmaceutical industry has different impacts on the technology...

Persistent link: https://www.econbiz.de/10010229875

Special FDA designations for drug development : orphan, fast track, accelerated approval, priority review, and breakthrough therapy

Michaeli, Daniel; Michaeli, Christoph T.; Albers, Sebastian - In: The European journal of health economics 25 (2024) 6, pp. 979-997

Persistent link: https://www.econbiz.de/10014633366

Private versus social incentives for pharmaceutical innovation

González, Paula; Macho-Stadler, Inés; … - 2015

We provide a theoretical framework to contribute to the current debate regarding the tendency of pharmaceutical companies to direct their R&D toward marketing products that are "follow-on" drugs of already existing drugs, rather than toward the development of breakthrough drugs. We construct a...

Persistent link: https://www.econbiz.de/10011406575

Creativity - a Volatile Key of Success? Creativity in New Drug Development

Sundgren, Mats; Styhre, Alexander - 2015

This paper presents a study of successful and creative projects in the pharmaceutical industry. Creativity is here defined as the ability to bring forth a new product within a specific domain of knowledge, namely in gastrointestinal, cardiovascular and oncological medicine. The paper, being...

Persistent link: https://www.econbiz.de/10014029811